Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The Disney-OpenAI deal and generative AI copyright concerns
This week’s Digiday Podcast delves into the copyright concerns and potential trademark issues surrounding brands’ use of generative AI tools, with Davis Wright Tremaine partner Rob Driscoll.
‘There’s tremendous opportunity’: NBA sponsorships lead on European expansion
David Brody, vp, global partner management group lead at the NBA, explains its pitch to sponsor brands and how expansion isn’t far off.
New partnerships, marketing fuel BNPL’s holiday surge
This holiday season, more brands deployed BNPL services with different payment options beyond the more familiar “pay-in-four” structure.